ERGOLINE AND TRYPTAMINE-BASED COMPOUNDS, AND USES OF THE SAME

This invention relates to pharmaceutically acceptable ergoline and tryptamine-based compounds (e.g. analogues, prodrugs and salts thereof). In particular, though not exclusively, the invention relates to formulations and uses of the same as a medicament, alone or in combination with additional pharm...

Full description

Saved in:
Bibliographic Details
Main Authors FALLON, Philip, VISHWAPATHI, Vinod, BUTLER, Philip Alan, GIBSON, David Christopher, YOUNG, Carl, WONG, Christopher, MATHESON, Christopher John, WILLIAMS, Sophie Caroline, NASH, Timothy, HENDERSON, Alistair Paul, GOLDING, Bernard Thomas, MOGHADDAM, Amir Lotfi, MCGAW, Oliver, MURATORE, Massimo, DOWNHAM, Robert
Format Patent
LanguageEnglish
French
Published 18.01.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to pharmaceutically acceptable ergoline and tryptamine-based compounds (e.g. analogues, prodrugs and salts thereof). In particular, though not exclusively, the invention relates to formulations and uses of the same as a medicament, alone or in combination with additional pharmaceutically acceptable compounds. La présente invention concerne des composés à base d'ergoline et de tryptamine pharmaceutiquement acceptables (par exemple des analogues, des promédicaments et des sels de ceux-ci). En particulier, bien que non exclusivement, l'invention concerne des formulations et leurs utilisations en tant que médicament, seuls ou en association avec des composés pharmaceutiquement acceptables supplémentaires.
Bibliography:Application Number: WO2023GB51872